Search

everythinglearnresearchcommunity

for

Search:↓

Adding vitamin D to metformin lowers blood sugar more than metformin alone in type 2 diabetes.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Working night shifts for four days can lower the body's ability to use insulin, which may increase the risk of type 2 diabetes.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Hair straightening products with glyoxylic acid can cause skin irritation and kidney damage.

The hydrogel helps heal diabetic wounds faster by reducing inflammation.

Semaglutide may cause hair loss, but more research is needed to confirm this.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Mice without active or present vitamin D receptors maintain normal blood sugar control and islet gene expression when calcium levels are normal.

Insulin might be involved in causing hair loss and acne.

Too much sugar harms skin, causing wrinkles and acne, but a low-sugar diet can help.

PCOS increases risks of gestational diabetes, hypertension, and caesarian deliveries in pregnancy.

Agarose/fucoidan hydrogels may help treat diabetes by supporting pancreatic cell growth.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Early detection, consistent management, and lifestyle changes are crucial for managing HAIR-AN syndrome effectively.

High insulin levels may increase the risk of pilonidal sinus disease in female teens.

A Rathke's cleft cyst caused hormonal imbalances and symptoms in a 68-year-old woman.

Changes in SHBG levels don't predict diabetes risk reduction.

Hair shedding is common in GLP-1 users, affecting treatment adherence.

People with moderate or severe hair loss are at a higher risk of dying from diabetes and heart disease.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Increased PHGDH expression causes early melanin buildup in hair follicles.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Early hair loss in young males may not be clearly linked to insulin resistance or metabolic syndrome.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Vitiligo and alopecia areata might be early signs of Type 1 Diabetes.